SCHEMBL23569348

SCHEMBL23569348

CCc1ccsc1S(=N)(N)=O

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5655444 0.86 CA2 (0.42) CA2
SCHEMBL22021505 0.81
SCHEMBL22021506 0.78 CA2 (0.32) CA2
SCHEMBL28090222 0.76 GABRA1 (0.32)
SCHEMBL21963283 0.76 NPSR1 (0.30)
SCHEMBL20681302 0.76 ALDH1A1 (0.40) CA2
SCHEMBL21962740 0.76 PTGS2 (0.33) CA2
SCHEMBL27866251 0.74 CA2 (0.31) CA2
SCHEMBL22021504 0.73 EDNRB (0.39) CA2
SCHEMBL5652598 0.73 CA2 (0.44) CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021123237-A1 2-AMINO-N-(AMINO-OXO-ARYL-LAMBDA6-SULFANYLIDENE)ACETAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE Oxford Drug Design Limited (GB) 2021-06-24 WO disclosed